Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harvard Bioscience

0.4825
+0.047410.89%
Post-market: 0.48250.00000.00%16:00 EDT
Volume:626.30K
Turnover:296.50K
Market Cap:21.33M
PE:-0.36
High:0.4925
Open:0.4605
Low:0.4500
Close:0.4351
Loading ...

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

GlobeNewswire
·
Yesterday

Harvard Bioscience Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
04 Aug

Harvard Bioscience Inc. Files Initial Statement of Beneficial Ownership for Director Seth Benson

Reuters
·
26 Jul

Harvard Bioscience Inc. Files Initial Statement of Beneficial Ownership for Director Robert E. Gagnon

Reuters
·
19 Jul

Harvard Bioscience: Strong Q2 Performance and Strategic Leadership Changes Drive Buy Rating

TIPRANKS
·
18 Jul

Harvard Bioscience Announces CEO Succession with John Duke Succeeding Jim Green, Adds Two New Independent Directors to Board

Reuters
·
17 Jul

Harvard Bioscience Inc. Faces Nasdaq Listing Non-Compliance Due to Audit Committee Vacancy

Reuters
·
24 Jun

Harvard Bioscience Inc. Announces Board Departure as Alan Edrick Resigns

Reuters
·
14 Jun

Harvard Bioscience Inc. Files Initial Beneficial Ownership Statement for Director John D. Duke

Reuters
·
10 Jun

Harvard Bioscience Approves Incentive Plan Amendment

TIPRANKS
·
03 Jun

Harvard Bioscience Inc. Appoints John Duke to Board of Directors, Katherine Eade Named Lead Independent Director

Reuters
·
03 Jun

Harvard Bioscience Inc. Files Initial Beneficial Ownership Statement for Interim CFO Mark T. Frost

Reuters
·
15 May

Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
14 May

Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark

TIPRANKS
·
13 May

Harvard Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May

Harvard Bioscience Q1 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $21.77M Beat $19.20M Estimate

Benzinga
·
12 May

Harvard Bioscience Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
10 May

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

GlobeNewswire
·
06 May

Harvard Bioscience Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
02 May

Harvard Bioscience CFO Jennifer Cote resigns, Mark Frost named interim CFO

TIPRANKS
·
11 Apr